Product Images Atorvastatin Calcium

This is a medication with the code number DD/DRUGS/DD/230 used under prescription-only (Rx Only) that contains Atorvastatin Calcium. Each tablet of the medication contains 10 mg of base. The medication is distributed by Ascend Laboratories in Parsippany, NJ, and manufactured in India. The remaining characters are not recognizable.*

Atorvastatin Calcium Tablets contain 10mg of atorvastatin and are stored at controlled room temperature. The tablets should be kept in tight containers out of the reach of children. Full prescribing information can be found in the package insert. The manufacturer is Alkem Laboratories Ltd. and they are distributed by Ascend Laboratories, LLC. The code number is not provided.*

This is a description for Atorvastatin Calcium Tablets USP. Each film-coated tablet contains 20mg of Atorvastatin Calcium. The tablets should be stored at a controlled room temperature of 20° to 25°C (68° to 77°F). The usual dosage should be based on the package insert for full prescribing information. Atorvastatin Calcium Tablets should be kept out of the reach of children and should be dispensed in tight containers. The manufacturer is Alkem Laboratories Ltd., and the product is distributed by Ascend Laboratories, LLC.*

Each tablet of this medicine contains Atorvastatin Calcium, USP equivalent to 40 mg of Atorvastatin. It is recommended to store the medication at a controlled room temperature and in tight containers. The usual dosage should be as per the package insert. This medicine is to be kept out of the reach of children. The tablets are manufactured in India by Akem Laboratories Ltd and distributed by Ascend Laboratories, LLC in Parsippany, NJ. The NDC number is 67877-513-10.*

This medication contains Atorvastatin Calcium and is dispensed in tight containers. The usual dosage can be found in the package insert. It is important to store the tablets in a controlled room temperature area. This product is manufactured by Alkem Laboratories Ltd. in India and distributed by Ascend Laboratories in Parsippany, NJ. The size and shape of the tablets are 64 x 39 mm. It is recommended to keep this medication out of the reach of children.*

This text presents data on the cumulative hazard percentage for a clinical trial comparing placebo to atorvastatin, a commonly used medication for lipid-lowering. The hazard ratio (HR) is reported as 0.63 with a confidence interval of 0.48-0.83 and a p-value of 0.001, suggesting that atorvastatin significantly reduces the risk of experiencing the primary endpoint over the course of four years. However, without knowing what the primary endpoint is, it is difficult to draw further conclusions. A survival curve is presented, showing time-to-event data over the four-year follow-up period.*

This is a medication study report that shows the percentage of subjects experiencing a cardiovascular event while taking Atorvastatin at two different doses (10mg and 80mg). The results indicate that Atorvastatin 80mg had a lower risk of cardiovascular events compared to Atorvastatin 10mg, with a Hazard Ratio (HR) of 0.78 (p=0.0002). The study also includes a chart showing the time to the first major cardiovascular endpoint over four years.*